Company intelligence / Profile preview

Agrematch

Rehovot, Central District, Israelagrematch.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Agrematch has demonstrated its technology by uncovering several active compounds using its proprietary AI-driven platform. The company's approach enables rapid discovery and validation of novel bioactive molecules for agricultural use, significantly reducing time and cost compared to traditional methods. It has entered strategic partnerships to accelerate product development but does not report clinical results as it operates outside the pharmaceutical sector.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Agriculture & AgTech

Drug pipeline

1 asset

AS9057

Pre-clinical

Indications: Herbicide

Partnerships

ICL Group (strategic partnership to develop novel biostimulant products for plant nutrition)

Beyond the preview

Go deeper on Agrematch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agrematch.

Explore the full profile